How Does Chronic Cigarette Smoke Exposure Affect Human Skin? A Global Proteomics Study in Primary Human Keratinocytes.
Cigarette smoking has been associated with multiple negative effects on human skin. Long-term physiological effects of cigarette smoke are through chronic and not acute exposure. Molecular alterations due to chronic exposure to cigarette smoke remain unclear. Primary human skin keratinocytes chronically exposed to cigarette smoke condensate (CSC) showed a decreased wound-healing capacity with an increased expression of NRF2 and MMP9. Using quantitative proteomics, we identified 4728 proteins, of which 105 proteins were overexpressed (≥2-fold) and 41 proteins were downregulated (≤2-fold) in primary skin keratinocytes chronically exposed to CSC. We observed an alteration in the expression of several proteins involved in maintenance of epithelial barrier integrity, including keratin 80 (5.3 fold, p value 2.5 × 10-7), cystatin A (3.6-fold, p value 3.2 × 10-3), and periplakin (2.4-fold, p value 1.2 × 10-8). Increased expression of proteins associated with skin hydration, including caspase 14 (2.2-fold, p value 4.7 × 10-2) and filaggrin (3.6-fold, p value 5.4 × 10-7), was also observed. In addition, we report differential expression of several proteins, including adipogenesis regulatory factor (2.5-fold, p value 1.3 × 10-3) and histone H1.0 (2.5-fold, p value 6.3 × 10-3) that have not been reported earlier. Bioinformatics analyses demonstrated that proteins differentially expressed in response to CSC are largely related to oxidative stress, maintenance of skin integrity, and anti-inflammatory responses. Importantly, treatment with vitamin E, a widely used antioxidant, could partially rescue adverse effects of CSC exposure in primary skin keratinocytes. The utility of antioxidant-based new dermatological formulations in delaying or preventing skin aging and oxidative damages caused by chronic cigarette smoke exposure warrants further clinical investigations and multi-omics research.
1 Institute of Bioinformatics , International Tech Park, Bangalore, India .|2 School of Biotechnology, KIIT University , Bhubaneswar, India .
Pavithra
P
Rajagopalan
1 Institute of Bioinformatics , International Tech Park, Bangalore, India .|3 Amrita School of Biotechnology , Amrita Vishwa Vidyapeetham, Kollam, India .
Vishalakshi
V
Nanjappa
1 Institute of Bioinformatics , International Tech Park, Bangalore, India .
Remya
R
Raja
1 Institute of Bioinformatics , International Tech Park, Bangalore, India .|2 School of Biotechnology, KIIT University , Bhubaneswar, India .
Ankit P
AP
Jain
1 Institute of Bioinformatics , International Tech Park, Bangalore, India .|3 Amrita School of Biotechnology , Amrita Vishwa Vidyapeetham, Kollam, India .
Kiran K
KK
Mangalaparthi
1 Institute of Bioinformatics , International Tech Park, Bangalore, India .|4 Manipal University , Manipal, India .
Gajanan J
GJ
Sathe
1 Institute of Bioinformatics , International Tech Park, Bangalore, India .
Niraj
N
Babu
1 Institute of Bioinformatics , International Tech Park, Bangalore, India .|3 Amrita School of Biotechnology , Amrita Vishwa Vidyapeetham, Kollam, India .
Krishna
K
Patel
5 L'Oréal Research and Innovation , Aulnay Sous Bois, France .
Nükhet
N
Cavusoglu
5 L'Oréal Research and Innovation , Aulnay Sous Bois, France .
Jeremie
J
Soeur
6 McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine , Baltimore, Maryland.|7 Department of Biological Chemistry, Johns Hopkins University School of Medicine , Baltimore, Maryland.|8 Department of Oncology, Johns Hopkins University School of Medicine , Baltimore, Maryland.|9 Department of Pathology, Johns Hopkins University School of Medicine , Baltimore, Maryland.
Akhilesh
A
Pandey
10 L'Oréal India, Bangalore, India .
Nita
N
Roy
5 L'Oréal Research and Innovation , Aulnay Sous Bois, France .
Lionel
L
Breton
1 Institute of Bioinformatics , International Tech Park, Bangalore, India .
Aditi
A
Chatterjee
10 L'Oréal India, Bangalore, India .
Namita
N
Misra
1 Institute of Bioinformatics , International Tech Park, Bangalore, India .
Harsha
H
Gowda
D002460:Cell Line; D002478:Cells, Cultured; D000091344:Filaggrin Proteins; D015870:Gene Expression; D006801:Humans; D015603:Keratinocytes / Q000378:metabolism*; D020780:Matrix Metalloproteinase 9 / Q000378:metabolism; D051267:NF-E2-Related Factor 2 / Q000378:metabolism; D018384:Oxidative Stress / Q000187:drug effects; D011506:Proteins / Q000378:metabolism*; D040901:Proteomics; D062326:Re-Epithelialization / Q000187:drug effects; D012867:Skin / Q000166:cytology / Q000378:metabolism*; D012906:Smoke / Q000009:adverse effects*; D012907:Smoking / Q000009:adverse effects*; D014026:Nicotiana / Q000009:adverse effects*; D014810:Vitamin E / Q000494:pharmacology / Q000627:therapeutic use
C000717249:FLG protein, human; D000091344:Filaggrin Proteins; D051267:NF-E2-Related Factor 2; C495635:NFE2L2 protein, human; D011506:Proteins; D012906:Smoke; D014810:Vitamin E; C579270:MMP9 protein, human; D020780:Matrix Metalloproteinase 9
biomarkers; multi-omics; proteomics; stratum corneum